## Abstract ## Background: Mutations in the maternally imprinted epsilon‐sarcoglycan gene occur in 30%–50% of myoclonus‐dystonia cases. Psychiatric symptoms, particularly obsessive‐compulsive disorder, have been described in some patients. ## Methods: We systematically reviewed 22 reports of psy
Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene
✍ Scribed by Friedrich Asmus; Farid Salih; Lena Elisabeth Hjermind; Karen Ostergaard; Marita Munz; Andrea A. Kühn; Erik Dupont; Andreas Kupsch; Thomas Gasser
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 240 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Primary dystonias represent a clinically and genetically heterogeneous group of movement disorders. Mutations in the ϵ‐sarcoglycan (SGCE) gene have been found recently to cause myoclonus–dystonia (MD). Considerable clinical variation of SGCE mutation carriers leads to the hypothesis tha
## Abstract The ϵ‐sarcoglycan gene (SGCE) on human chromosome 7q21 has been reported to be a major locus for inherited myoclonus–dystonia. Linkage to the SGCE locus has been detected in the majority of families tested, and mutations in the coding region have been found recently in families with aut
## Abstract In a Chinese myoclonus‐dystonia syndrome (MDS) family presented with a phenotype including a typical MDS, cervical dystonia, and writer's cramp, genetic analyses revealed a novel 662 + 1insG heterozygous mutation in exon 5 in the ε‐sarcoglycan (__SGCE__) gene, leading to a frameshift wi
## Abstract We describe two affected individuals in a family with myoclonus–dystonia syndrome complicated with severe depression. One individual committed suicide. Molecular genetic analysis revealed a heterozygous point mutation in the ε‐sarcoglycan gene, which we show leads to skipping of exon 5.
## Abstract Neuroferritinopathy is a recently recognized autosomal dominant disorder that results in abnormal aggregates of iron and ferritin in the brain due to a mutation in the ferritin light chain gene on chromosome 19q13.3. We present the clinical details of a patient with adult‐onset generali